НовостиBenzingaCanaccord Genuity Initiates Coverage On Parabilis Medicines with Buy Rating, Announces Price Target of $39 Canaccord Genuity Initiates Coverage On Parabilis Medicines with Buy Rating, Announces Price Target of $39 Benzinga 2026.11.09 18:00 (GMT+0) Открыть на Benzinga Другие новости